PRESS RELEASE published on 09/01/2023 at 18:00, 2 years 8 months ago BIOSYNEX SA: DECLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 31 AOÛT 2023
PRESS RELEASE published on 08/01/2023 at 18:00, 2 years 9 months ago BIOSYNEX SA: DECLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 31 JUILLET 2023
PRESS RELEASE published on 07/21/2023 at 08:00, 2 years 9 months ago BIOSYNEX SA: ACQUISITION DE LA TOTALITE DU CAPITAL DE LA SOCIETE QUALIGEN INC. PAR CHEMBIO INC.
PRESS RELEASE published on 07/20/2023 at 18:00, 2 years 9 months ago BIOSYNEX SA: CHIFFRE D’AFFAIRES DU 1er SEMESTRE 2023 : 42,8 M€
PRESS RELEASE published on 07/04/2023 at 08:30, 2 years 10 months ago BIOSYNEX SA: DÉCLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 30 JUIN 2023
PRESS RELEASE published on 06/12/2023 at 08:30, 2 years 10 months ago BIOSYNEX SA: PRISE DE CONTROLE ET ACQUISITION DE LA TOTALITE DU CAPITAL DE LA SOCIETE PROCISEDX
PRESS RELEASE published on 06/08/2023 at 18:00, 2 years 11 months ago BIOSYNEX SA: BIOSYNEX ANNONCE L’ACQUISITION DE L’ACTIVITE « SOINS OCULAIRES » DES LABORATOIRES INNOXA
PRESS RELEASE published on 06/02/2023 at 18:00, 2 years 11 months ago BIOSYNEX SA: DECLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 31 MAI 2023
PRESS RELEASE published on 05/05/2023 at 18:02, 3 years ago BIOSYNEX SA: DECLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 30 AVRIL 2023
PRESS RELEASE published on 04/27/2023 at 23:30, 3 years ago BIOSYNEX SA: REALISATION DE L’ACQUISITION DE CHEMBIO DIAGNOSTICS, INC.
Published on 05/09/2026 at 00:00, 1 hour 30 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:00, 2 hours 30 minutes ago Digi Power X Announces Upsizing of At-the-Market Offering Program
Published on 05/08/2026 at 22:30, 3 hours ago Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026
Published on 05/08/2026 at 22:30, 3 hours ago Sekur Private Data Advances Defense-Grade Secure Communications Platform
Published on 05/08/2026 at 20:38, 4 hours 52 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 6 hours 17 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 6 hours 28 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 6 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 6 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 6 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 6 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 6 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
